Home > Products > CA19-9 & CD3
> Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (Minibody)
Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (Minibody) (CAT#: MiniB-026)
Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (Minibody) is designed to be expressed as the anti-CA19-9 scFv fused to N-terminus of Knob-CH3 domain and the anti-CD3 scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget T cells to tumor cells. It is designed for the research of Ovarian cancer; Pancreatic cancer; Gastric cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (Minibody) (MiniB-026). Click the button below to contact us or submit your feedback about this product.